Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis
Authors:
Open Access
- 28 December 2009
- journal article
- systemic lupus-erythematosus
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (1) , 245-249
Abstract
Objective It has been reported that a single dose of human C‐reactive protein (CRP) can prevent and reverse the renal damage in murine models of spontaneous lupus, as well as the rapid‐onset immune complex disease induced in the accelerated nephrotoxic nephritis (ANTN) model. This study was undertaken to attempt to replicate these observations using a highly purified and fully characterized human CRP preparation. Methods (NZB × NZW)F1 (NZB/NZW) mice were treated with a single 200‐μg subcutaneous injection of CRP or control reagents either before disease onset at 4 months of age or when high‐grade proteinuria was present at 7 months of age. Mice were monitored at least monthly for proteinuria and autoantibody levels. ANTN was induced by preimmunizing C57BL/6 mice with sheep IgG, followed 5 days later by injection of sheep anti‐mouse glomerular basement membrane antibody and CRP or control reagents. Renal disease was assessed by regular urinalysis and histologic evaluation. Results CRP treatment of NZB/NZW mice, either early or late in the disease, had no effect on proteinuria, autoantibody titers, or survival. CRP administration did not reduce renal injury or alter disease in the ANTN model. Human serum amyloid P component, a pentraxin protein that is very closely related to CRP, similarly had no effect. Conclusion Our completely negative observations do not confirm that human CRP has reproducible antiinflammatory or immunomodulatory effects in these murine models, nor do they support the suggestion that CRP might be useful for therapy of lupus or immune complex–mediated nephritis.Keywords
This publication has 14 references indexed in Scilit:
- Genetic Dissection of Spontaneous Autoimmunity Driven by 129-Derived Chromosome 1 Loci When Expressed on C57BL/6 MiceThe Journal of Immunology, 2007
- C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fcγ ReceptorsThe Journal of Immunology, 2007
- Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C‐reactive proteinArthritis & Rheumatism, 2005
- Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein ItselfCirculation Research, 2005
- Reversal of ongoing proteinuria in autoimmune mice by treatment with C‐reactive proteinArthritis & Rheumatism, 2005
- The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.Journal of Clinical Investigation, 1994
- Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoliClinical and Experimental Immunology, 1994
- Decreased Autoantibody Levels and Enhanced Survival of (NZB × NZW) F1 Mice Treated with C-Reactive ProteinClinical Immunology and Immunopathology, 1994
- Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosisClinical and Experimental Immunology, 1991
- C-REACTIVE PROTEIN FIFTY YEARS ONThe Lancet, 1981